WEITZMAN DEBORAH (CEO, Pharmaceutical Segment) reported 1 transaction at CARDINAL HEALTH INC
Review the transaction codes below to understand the nature of each event.
Filed: 12/2/2025ACC: 0001942639-25-000005
Officer· CEO, Pharmaceutical Segment
Since Sep 2022
-551.00
Net shares
Net seller
$117.0K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
551.00 disposed
Non-Derivative Transactions1
Common Shares
Direct
Shares
−551.00
Price / share
$212.26
Trade value
$116.96K
% of position
1.0%
12/1/2025
53.43K→52.88K
Total
Net shares
−551.00
Net value
-$116.96K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 12/1/2025 | F · Tax Withholding | −551.00 | $212.26 | $116.96K | 1.0% | 53.43K | 52.88K |
| Total | −551.00 | -$116.96K | ||||||
Derivative Transactions0
No derivative transactions reported